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Abstract A model system is presented using human umbili-
cal vein endothelial cells (HUVECs) to investigate the role of
homocysteine (Hcy) in atherosclerosis. HUVECs are shown
to export Hcy at a rate determined by the flux through the
methionine/Hcy pathway. Additional methionine increases
intracellular methionine, decreases intracellular folate, and
increases Hcy export, whereas additional folate inhibits ex-
port. An inverse relationship exists between intracellular
folate and Hcy export. Hcy export may be regulated by in-
tracellular 
 
S
 
-adenosyl methionine rather than by Hcy. Hu-
man LDLs exposed to HUVECs exporting Hcy undergo
time-related lipid oxidation, a process inhibited by the thiol
trap dithionitrobenzoate. This is likely to be related to the
generation of hydroxyl radicals, which we show are associ-
ated with Hcy export. Although Hcy is the major oxidant,
cysteine also contributes, as shown by the effect of glutamate.
Finally, the LDL oxidized in this system showed a time-depen-
dent increase in uptake by human macrophages, implying an
upregulation of the scavenger receptor.  These results sug-
gest that continuous export of Hcy from endothelial cells con-
tributes to the generation of extracellular hydroxyl radicals,
with associated oxidative modification of LDL and incorpo-
ration into macrophages, a key step in atherosclerosis. Fac-
tors that regulate intracellular Hcy metabolism modulate these
effects.
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Homocysteine (Hcy) is the demethylated derivative of
methionine (1), and there is a well-established epidemio-
 
logical relationship between total plasma homocyst(e)ine
concentration (tHcy) and cardiovascular disease risk (2–5).
It has been estimated that 10% of the population risk for
cardiovascular disease in the United States is associated
with increased tHcy (6). Increased plasma tHcy is linked
to increased risk of cardiovascular disease to a similar ex-
tent to that of smoking and hyperlipidemia, which strength-
ens the link between smoking and hypertension (7). How-
ever, although the epidemiological evidence strongly
supports a connection, it does not provide strong support
for increased tHcy being a cause of cardiovascular disease.
Most prospective studies support a causative link (8), but
there remains considerable doubt (9). There has thus
been considerable research into the association between
plasma tHcy and cardiovascular disease, and it has been
suggested that the reduced form, Hcy, in the presence of
suitable catalysts such as transition metals, is responsible
for the oxidation of LDL, which is subsequently taken up
by macrophages, converting them into foam cells and
leading to the formation of arterial plaques (10). Al-
though this theory has received general support, a num-
ber of problems remain, not least the fact that Hcy in
plasma is rapidly oxidized, so that Hcy forms only approx-
imately 1% of the tHcy in plasma (11). Some authors have
suggested that tHcy in vivo may be an antioxidant and not
a prooxidant at all (12–14). We have explored the putative
antioxidant and prooxidant activities of Hcy and have
demonstrated that prooxidant activity occurs across the
physiological range of concentrations of Hcy (15).
 
Abbreviations: DiI, 1,1
 

 
-dioctadecyl-3,3,3
 

 
,3
 

 
-tetramethylindocar-
bocyanine perchlorate; DMPO, 5,5-dimethyl-1-pyrroline 
 
N
 
-oxide; EPR,
electron paramagnetic resonance; Hcy, homocysteine; HUVEC, human
umbilical vein endothelial cell; SAM, 
 
S
 
-adenosyl methionine; TBARS,
thiobarbituric acid reactive substances; tHcy, total homocysteine.
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Previous groups have shown the oxidative potential of
extracellular thiols in cellular systems, presumably through
thiol export and subsequent oxidation (16–18). Hcy in
the plasma has to be a product of export from cells; there-
fore, the oxidative potential of Hcy toward LDL is likely to
be determined by the rate of Hcy export from cells and
the subsequent rate of its oxidation. A variety of cells in
culture can evidently export Hcy, and the rate of export
appears to reflect flux through the methionine/Hcy path-
way (
 
Fig. 1
 
) (19–22). Different cell types have very differ-
ent export rates: hepatocytes have been reported to have a
high rate of Hcy export, whereas quiescent lymphocytes
and fibroblasts have a much slower export (19). High cell
density has been shown to decrease Hcy export (19, 23).
One group (24) has also shown that additional folate in
the medium reduces Hcy export, although those workers
did not use a folate-free medium as a test control.
We have therefore undertaken a methodical analysis of
Hcy export and its effect on LDL oxidation. We have pre-
viously shown that Hcy is a prooxidant at physiological
concentration and that it most likely acts by generating
free radicals on oxidation (15). Here, we investigate the
hypothesis that it is the slow continuous production of
Hcy by endothelial cells that is responsible for the athero-
genic effect of tHcy. We demonstrate the involvement of the
hydroxyl radical in the oxidation. We further show that the
oxidized LDL produced in this way is internalized by mac-
rophages, indicating that continuous production of Hcy
by endothelial cells is likely to be a major oxidant for LDL.
MATERIALS AND METHODS
 
Materials
 
All chemicals were obtained from Sigma Chemical Co. (Lon-
don, UK) unless otherwise stated.
 
Cell culture media
 
Basal medium for the maintenance of freshly isolated human
umbilical vein endothelial cells (HUVECs) and for the experi-
mental systems was prepared specially by Gibco as the standard
MCDB131 medium but without any methionine or folate in any
form. To this medium, glutamine (2 mM), epidermal growth fac-
tor (10 ng/ml), holotransferrin (5 
 

 
g/ml), insulin (5 
 

 
g/ml),
penicillin (100 U/ml), and streptomycin (100 
 

 
g/ml) were added.
For the growth medium, fetal calf serum (20%; Gibco), methio-
nine (100 
 

 
M), and folinic acid (25 nM) were added. For the test
medium, instead of these we added endothelial cell growth sup-
plement (50 
 

 
g/ml; Firstlink) and Albumax (20 mg/ml; Gibco).
For experiments examining the effect of additional folate, folinic
acid was also added at 10, 100, or 1,000 nM.
 
Isolation and culture of HUVECs
 
Human umbilical cords from normal deliveries were collected
from the Maternity Unit, Jessop Hospital for Women, Sheffield,
into a bottle containing 40 ml of DMEM supplemented with 100
U/ml penicillin, 100 
 

 
g/ml streptomycin, 2.5 
 

 
g/ml amphoteri-
cin B, 100 
 

 
g/ml gentamycin, and 20 mM HEPES and stored at
4
 

 
C. Ethical approval to collect umbilical cords was obtained from
the North Sheffield Research Ethics Committee. Cords were pro-
cessed within 48 h of birth, and all procedures were carried out
in a class II cabinet. Cords were washed with DMEM and treated
with 1,200 U/ml collagenase type IV for 10 min at room temper-
ature. The digest was centrifuged, resuspended in growth medium,
and seeded onto 0.2% gelatin-coated T75 flasks (Costar, Inc.)
and incubated at 37
 

 
C in a 5% CO
 
2
 
 atmosphere. Typically, one
15 cm cord was seeded into one T75 flask. When the cells
reached confluence (5–7 days), they were passaged by treatment
with trypsin/EDTA (0.5 g/l trypsin and 0.02% EDTA in Hank’s
buffered saline solution) and split to produce 8 
 

 
 10
 
5
 
 cells per
T75 flask (typically a 1:3 split). After 4 days, cells were passaged
onto gelatin-coated 6-well (2 
 

 
 10
 
5
 
 cells/well) or 24-well (7.5 
 

 
10
 
4
 
 cells/well) plates depending on the experiment. Medium was
renewed every 2–3 days throughout. At confluence (3–4 days),
the medium was changed to test medium for experimental work.
HUVECs were characterized by positive immunofluorescence
for von Willebrand factor, CD31, and 
 
Ulex europeaeus
 
 agglutinin.
Cells were fixed using cold methanol/acetone, washed in PBS,
permeabilized by 0.5% Triton X-100, and washed in PBS. For von
Willebrand factor and CD31 (antibodies from Novocastra Labs
and R&D Systems, respectively), the primary antibody was ap-
plied as a 1:50 or 1:100 dilution, respectively, in phosphate-buff-
ered saline plus 1% skimmed milk powder. Cells were left for 1 h,
washed, treated with a secondary FITC-conjugated goat anti-
mouse antibody (Sigma) at a 1:150 dilution, incubated for 1 h,
washed, and stained with Hoechst 33342. For 
 
U. europeaeus
 
 agglu-
tinin, a FITC-conjugated antibody was used directly (Vector Lab-
oratories), diluted to 20 
 

 
g/ml. Fluorescence was observed using
a Leica fluorescence microscope.
All experiments were performed with at least three different
HUVEC isolates.
Fig. 1. The remethylation pathway of homocysteine (Hcy).
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Cell viability
 
Cell viability was measured at the end of each experiment by
staining with 10 
 

 
M Hoechst 33342 and 10 
 

 
M propidium io-
dide (Hcy export experiments) or 0.05% trypan blue (all other
experiments).
 
LDL preparation
 
LDL was prepared as described (25). Briefly, freshly obtained
human plasma was centrifuged in an iodixanol solution (2.5 h,
100,000 rpm). The LDL-rich fraction was collected and assayed
for cholesterol using a Sigma kit (401-25P). All experiments were
carried out at a LDL protein concentration of 100 
 

 
g/ml. LDL
in suspension was stored at 4
 

 
C under nitrogen and used within
3 days. All experiments were carried out using LDL isolated from
a single volunteer, for consistency.
 
Measurement of extracellular homocyst(e)ine
 
tHcy in the medium was measured by a fully automated fluo-
rescence polarization immunoassay using an IMX analyzer (Ab-
bott Diagnostics), and each set of measurements was calibrated
and checked against standards. The assay has a coefficient of
variation of 
 

 
2% within runs and 4.5% between runs.
 
Measurement of intracellular homocyst(e)ine and 
intracellular and extracellular methionine
 
Cells were detached from T75 flasks using trypsin/EDTA,
washed, counted, weighed, and resuspended in MCDB131 be-
fore storage at 
 

 
80
 

 
C for later use. For preparation of the final
cell extract, the suspension was thawed and cells were drawn up
into a 20 gauge needle several times to break up any intact cells.
tHcy and methionine were measured in supernatants after cen-
trifugation.
tHcy in cell lysates was measured by HPLC with fluorescence
detection as previously described, with modifications (26). Lysate
(50 
 

 
l) was added to 100 
 

 
l of cysteamine (internal standard).
The sample was then treated with 30 
 

 
l of 10% tri-butylphos-
phine in dimethylformamide to reduce disulfide bonds between
Hcy and proteins and between other thiols. Plasma proteins were
removed by deproteinization with 100 
 

 
l of 10% trichloroacetic
acid, and samples were then centrifuged at 3,000 
 
g
 
 for 10 min.
Fifty microliters of the resulting supernatant was added to 100 
 

 
l
of borate buffer (2.5 M, pH 10.5) and 30 
 

 
l of 7-fluoro-2,1,3-
benzoxadiole-4-sulfonamide (1 mg/ml in borate buffer) to per-
mit subsequent fluorimetric detection. This mixture was then in-
cubated for 1 h at 60
 

 
C. tHcy was separated on a Nucleosil 120 C18
(4.6 
 

 
 250 mm, 5 
 

 
m) column (Jones Chromatography) with
isocratic elution at a flow rate of 1.0 ml/min with a 0.1 M potas-
sium phosphate buffer, pH 2.1, containing 4.5% acetonitrile.
Methionine concentrations in cell lysates and medium were
measured by HPLC with fluorescence detection according to
Potgieter et al. (27), with slight modifications. Fifty microliters of
lysate was added to 50 
 

 
l of the internal standard (
 
d,l
 
-hydroxy-
norvaline, 100 
 

 
M). Proteins were removed by the addition of
500 
 

 
l of acetonitrile while mixing vigorously. The resulting su-
pernatant was removed, evaporated to dryness under nitrogen,
and then reconstituted in HPLC buffer. For precolumn derivati-
zation with 
 
o
 
-phthaldialdehyde, 20 
 

 
l of the eluate was mixed
with 20 
 

 
l of 
 
o
 
-phthaldialdehyde and then injected onto the
HPLC column [Phenomenex Prodigy C18, reverse phase (RP),
150 
 

 
 4.6 mm]. Methionine was separated using a two-solvent
gradient system at a flow rate of 1 ml/min.
 
Measurement of intracellular folate
 
Cells were detached using trypsin/EDTA, washed, counted,
suspended in lysis buffer (Abbott Laboratories), and disrupted
by freezing at 
 

 
80
 

 
C for 3 days and thawing. The resulting sus-
pension was centrifuged at 150,000 
 
g
 
 to produce a clear superna-
tant, and the total folate concentration was measured using a
commercial Ion Capture Assay System (Abbot IMX; Abbott Labo-
ratories). Results were obtained as folate per cell (counted using
a hemocytometer). The assay has a coefficient of variation of
 

 
4.7% within runs and 5.2% between runs.
 
Measurement of free radicals in the medium
 
Confluent HUVECs were cultured on six-well plates in test me-
dium containing 100 
 

 
M methionine plus 1 mM 5,5-dimethyl-
1-pyrroline 
 
N
 
-oxide (DMPO) as a spin trap and 30 
 

 
M copper. At
various times, the medium was collected, centrifuged to remove
suspended cells, and frozen until required for measurement of
free radicals. Thawed samples were placed in an electron para-
magnetic resonance (EPR) quartz flat cell and mounted in the
instrument cavity. First derivative EPR spectra were obtained on a
Bruker EMX 6/1 EPR spectrometer operating at X-Band fre-
quency range (9.7 GHz) and a modulation frequency of 100
kHz. Instrument settings were as follows: field set, 3,488 Gauss
(G); scan width, 100 G; microwave power, 5 mW; modulation am-
plitude, 1.5 G; time constant, 10.24 ms; scan time, 83.89 s. For
purposes of comparison, the hydroxyl radical was independently
generated by the Fenton reaction and the superoxide radical an-
ion, O
 
2
.
 

 
, was generated by the xanthine oxidase enzyme-cata-
lyzed oxidation of xanthine to uric acid in the presence of DMPO.
Spectral simulations were performed using the SimFonia pro-
gram from Bruker.
 
Measurement of lipoprotein oxidation
 
To HUVECs in test medium on six-well plates, LDL was added
to a concentration of 100 
 

 
g LDL protein/ml. Cuprous sulfate
was also added at 30 
 

 
M. When required, the thiol-blocking
agent DTNB or glutamate, which inhibits cystine uptake into
cells, was added at 500 
 

 
M or 10 mM, respectively. The plates
were incubated for up to 72 h at 37
 

 
C. Butylated hydroxytoluene
(final concentration 500 
 

 
M) and diethylenetriaminepentaace-
tic acid (final concentration 1 mM) were added to prevent fur-
ther oxidation. LDL lipid oxidation was measured by monitoring
the product of the reaction with thiobarbituric acid, using the
thiobarbituric acid reactive substances (TBARS) assay (13, 28) as
previously described (15).
 
Preparation of macrophages
 
All containers and pipettes were washed in Sigmacote and al-
lowed to dry. Blood was collected from a healthy human volun-
teer into 0.4% sodium citrate. Blood was diluted 2:5 with sterile
PBS containing 0.1% BSA. This was layered over Lymphoprep and
centrifuged for the removal of platelets (160 
 
g
 
, 15 min, 20
 

 
C).
Further centrifugation (350 
 
g
 
, 20 min, 20
 

 
C) allowed mononu-
clear cells to be collected (29). Mononuclear cells were washed
and resuspended in RPMI 1640 medium (Gibco) containing
10% fetal calf serum and pipetted onto 96-well plates at 2 
 

 
 10
 
6
 
cells/ml. After overnight culture at 37
 

 
C in 5% CO
 
2
 
, nonadher-
ent cells were removed by washing, and RPMI medium contain-
ing 10% fetal calf serum and 50 ng/ml macrophage colony-stim-
ulating factor was added. Medium was replaced every 2 days.
After 5 days, the cells had differentiated into macrophages, as
shown by visual inspection and by positive immunofluorescence
for CD206 antibody.
 
Determination of macrophage uptake of oxidized LDL
 
A standard fluorescent fully oxidized LDL sample was pre-
pared. LDL was oxidized (15) over 5 h at 37
 

 
C in the presence of
copper because a TBARS assay showed that oxidation was com-
plete by this time. The sample was partially buffer-exchanged
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and concentrated to 1 mg/ml LDL protein in HBS (HEPES-buff-
ered saline: 0.14 M NaCl, 10 mM HEPES, pH 7.4) using a 10 kDa
molecular mass cutoff Vivaspin ultrafiltrator (Vivascience). The
purified LDL was allowed to react (4:1, v/v) overnight at 37
 

 
C
with 1,1
 

 
-dioctadecyl-3,3,3
 

 
,3
 

 
-tetramethylindocarbocyanine per-
chlorate (DiI; as a 1.07 mM solution in dimethyl sulfoxide). After
the reaction, the buffer was exchanged using a second Vivaspin
ultrafiltrator. The DiI-labeled LDL was stored at 
 

 
80
 

 
C until
needed.
The method used to determine macrophage uptake of oxi-
dized LDL was based on that described by Griffiths et al. (30),
with important modifications. In preliminary experiments, incu-
bation of macrophages with different amounts of DiI-labeled
LDL produced a linear increase in fluorescence up to an addi-
tion of 25 
 

 
g of LDL protein per well (210 
 

 
l). Therefore, a stan-
dard protocol was adopted, in which 10 
 

 
g/well DiI-labeled LDL
was added to the cells, together with 20 
 

 
g/well partially oxi-
dized LDL, obtained by incubating LDL in our standard experi-
mental system (100 
 

 
M methionine, 30 
 

 
M copper) for different
periods of time and stored at 
 

 
80
 

 
C until needed. Cells were in-
cubated with the LDL mixture for 16 h at 37
 

 
C, washed twice
with PBS, and lysed with 5% Triton X-100. The fluorescence of
each well was measured using a plate reader, with an excitation
wavelength of 544 nm and an emission wavelength of 590 nm.
 
Statistical tests
 
Statistical tests were carried out using SPSS 10.0 for Windows.
For comparisons of the effects of different treatments, the num-
bers of data points were not considered sufficient for parametric
tests; therefore, the Mann-Whitney test was used. For analysis of
time-dependent changes, a Kruskal-Wallis 
 
H
 
 test was used. Associ-
ation between intracellular folate and exported Hcy was investi-
gated using linear regression analysis.
 
RESULTS
 
Hcy export from HUVECs
 
Except where indicated otherwise, at least 80% of cells
were viable after incubation for up 72 h in test medium.
The cells were of normal appearance and stained positive
with antibodies against von Willebrand factor, 
 
U. europe-
aeus
 
 agglutinin, and CD31, demonstrating that they still
retained the characteristics of endothelial cells.
Confluent HUVECs were incubated in media to which
methionine had been added at 0, 100, or 200 
 

 
M and to
which folinic acid had been added at concentrations be-
tween 0 and 1,000 nM. Folinic acid was used as a more sta-
ble precursor of 5-methyl tetrahydrofolate, the main circu-
lating form of folate in the body. Cells exported Hcy at a
constant rate for at least 72 h (
 
Fig. 2
 
). Addition of 100 
 

 
M
methionine to the test medium led to a marked and statis-
tically significant increase in the rate of Hcy export from
the cells, which was further increased, but not signifi-
cantly, on further increasing the concentration of me-
thionine (Fig. 2). By contrast, addition of folate (in the
form of folinic acid) led to a dose-dependent decrease in
the rate of Hcy export, which reached significance at 72 h
(
 
Fig. 3
 
).
These results are consistent with the export of Hcy re-
flecting an imbalance between the production of Hcy and
its metabolism by means of remethylation (Fig. 1). We
therefore investigated the relationship between Hcy ex-
port and the intracellular concentration of folate, a key
determinant of the remethylation rate. The concentra-
tion of intracellular total folate decreased slowly over the
course of 72 h in culture. Addition of methionine to the
culture medium markedly enhanced the observed de-
crease in intracellular folate (
 
Fig. 4
 
). Intracellular folate
was responsive to additional extracellular folate in a dose-
response manner but increased only by a factor of 2 in re-
sponse to a 10-fold increase in extracellular folate (
 
Fig. 5
 
),
suggesting that transport of folate across the cell mem-
brane is tightly regulated. In the absence of additional fo-
linic acid in the medium, a strong negative correlation
was shown between intracellular folate and extracellular
Hcy (
 
R
 
 
 

 
 
 

 
0.71, 
 
P
 
 
 

 
0.005) (
 
Fig. 6
 
).
We also investigated the concentration of intracellular
Hcy in the presence and absence of extracellular me-
Fig. 2. Export of Hcy from human umbilical vein endothelial
cells (HUVECs). The effect of the addition of methionine (100 and
200 M) to the medium is indicated. Bars indicate the addition of
0, 100, and 200 M methionine (open, striped, and dotted bars, re-
spectively). Results are derived from five measurements on three in-
dependent HUVEC cultures. Error bars denote standard devia-
tions. Asterisks show significant differences compared with time 0:
* P  0.05, ** P  0.01. For each set of conditions, the increase in
Hcy with time is significant (P  0.05).
Fig. 3. Effect of adding folinic acid on Hcy export. Bars indicate
control (no methionine) and solutions with 100 M methionine
plus the addition of 0, 10, 100, and 1,000 nM folinic acid (open,
vertical striped, dotted, horizontal striped, and wavy bars, respec-
tively). Results are derived from five experiments on three indepen-
dent HUVEC cultures. Error bars denote standard deviations. As-
terisks show significant differences from the 100 M methionine,
0 nM folinic acid value at P  0.05.
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thionine (
 
Fig. 7
 
). Unexpectedly, the results showed an in-
crease in intracellular Hcy in the absence of extracellular
methionine but relatively little change in the presence of
methionine. Correcting for cell number made no differ-
ence to the time/concentration profile. This result was
unexpected because we had already demonstrated that
additional methionine increases Hcy export and had pre-
sumed this to occur via increased flux from increased in-
tracellular methionine. We therefore measured intracellu-
lar methionine in cell extracts collected in duplicate from
a single experiment. Methionine concentration changed
from a baseline 3.1 nmol/10
 
6
 
 cells through 3.7 at 24 h, 4.8
at 48 h, and 5.3 at 72 h, confirming the anticipated in-
crease. In contrast, the concentration of methionine in
the medium decreased from 107 
 

 
M at baseline, through
97, 82, and 78 
 

 
M at 24, 48, and 72 h, respectively. We sug-
gest that the reason for this observation lies in the well-
established link between 
 
S
 
-adenosyl methionine (SAM)
and Hcy metabolism. Increase in extracellular methio-
nine leads to an increase of intracellular methionine, which
in turn should lead to an increase in SAM. SAM inhibits
 
N
 
5,10
 
-methylenetetrahydrofolate reductase (31) and also
stimulates the transsulfuration pathway, which is a meta-
bolic route to remove Hcy in liver (32). Endothelial cells
have little or no transsulfuration activity and can only re-
move excess Hcy by export from the cell (33). Therefore,
we suggest that an increase in the concentration of intra-
cellular SAM may stimulate Hcy export, regulating intracel-
lular Hcy and acting as a major determinant of the plasma
concentration of tHcy. This is in contrast with an earlier
suggestion (34) that the intracellular Hcy/SAM ratio might
regulate Hcy export.
 
Generation of free radicals
 
HUVECs were cultured in the presence of DMPO,
which acts as a spin trap. EPR spectra of the cell superna-
tants were recorded after various growth periods. The ma-
jor signal recorded gave Hamiltonian parameters deter-
mined to be A
 
N
 
 
 

 
 14.84 G and A
 
H
 
 
 

 
 14.84 G. These
measurements were confirmed by fitting simulations to be
characteristic of the hydroxyl radical, HO
 
•
 
, and are for ex-
ample quite distinct from sulfhydryl radicals (
 
Fig. 8
 
) (35).
In the absence of cells, a weak signal was recorded. This is
thought to arise from the medium composition, which
might comprise hydroxyl radical-generating factors like
amino acids together with metal ions, which are capa-
ble of Fenton-type reactions. A slight time-dependent in-
Fig. 4. Intracellular folate concentration in HUVECs. The results
are from 12 experiments using four independent HUVEC cultures
and are presented as means 	 SD. The effect of the addition of 100
M methionine to the medium is shown (closed bars) and com-
pared with results in the absence of methionine (open bars). Aster-
isks denote significant differences at the P  0.005 level.
Fig. 5. Effect of extracellular folinic acid on intracellular folate
concentrations. Bars indicate the addition of 0, 100, and 1,000 nM
folinic acid (open, striped, and dotted bars, respectively). The re-
sults are from seven experiments using four independent HUVEC
cultures and are presented as means 	 SD. Asterisks show signifi-
cant differences from the 0 nM folinic acid values (P  0.005).
Fig. 6. Association between intracellular folate and extracellular
Hcy. Measurements were made on three different HUVEC prepara-
tions after various periods of growth up to 72 h (R  0.71).
Fig. 7. Intracellular Hcy concentration. The results are from two
experiments using two independent HUVEC cultures and are pre-
sented as means 	 SD. The effect of the addition of 100 M me-
thionine to the medium is shown (closed bars) and compared with
results in the absence of methionine (open bars). Asterisks show
significant differences with methionine (P  0.05).
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crease in intensity was also recorded. However, on incuba-
tion with HUVECs, a higher level of hydroxyl radical was
recorded, with a much higher rate of increase over time
compared with samples in the absence of cells (
 
Fig. 9
 
).
The higher rate of increase in hydroxyl radical produc-
tion in the presence of cells was continuous over the time
of the experiment (48 h). We have thus shown that the
major reactive oxygen species (ROS) in our Hcy-mediated
cellular oxidative reactions is specifically the hydroxyl rad-
ical. Incubation with the thiol blocker DTNB reduced the
concentration of the hydroxyl radical generated in the
cellular system (Fig. 9). Incubations in the presence of a
range of copper concentrations showed a concentration-
dependent increase in hydroxyl radical (F. A. Taiwo, D.
Nugent, E. Nakano, H. Griffiths, and H. J. Powers, unpub-
lished data), consistent with the expected importance of
copper in the free radical generation process.
 
LDL oxidation
 
LDL was oxidized more rapidly in the presence of HU-
VECs than in their absence (
 
Table 1
 
). Addition of DTNB
to the medium led to a significant reduction in the extent
of LDL oxidation (Table 1). Control experiments carried
out in the absence of copper produced very slow oxida-
tion of LDL, as expected (15).
It has been suggested that DTNB (or more specifically
the TNB
 

 
 anion) acts independently as an antioxidant
(18). It is therefore important to establish whether the ef-
fect of DTNB on LDL oxidation is simply a direct antioxi-
dant effect or whether it is achieved through prevention
of oxidation of the thiol groups on Hcy. The above exper-
iment was also carried out in the absence of cells. There
was a small reduction in the amount of oxidized LDL gen-
erated (Table 1), but the change was much less significant
than in the presence of HUVECs. Thus, we conclude that
although DTNB may have some antioxidant activity, most
of the effect seen here is attributable to the blocking of
thiol groups.
Cysteine can be exported from endothelial cells and
may contribute to the oxidation of LDL in our system. To
minimize this contribution, glutamate was added to the
incubation medium to inhibit cystine uptake and thereby
reduce cysteine export (18). Addition of 15 mM glutamate
to the medium had no significant effect on the concentra-
tion of extracellular Hcy (data not shown) but led to a
modest but significant reduction in the extent of LDL oxi-
dation (
 
Table 2
 
). These values suggest that the export of
cysteine may have contributed 
 

 
50% to the overall oxida-
tion of LDL. The results in Table 2 are shown at 24 h only,
because by 48 h in the presence of glutamate and LDL,
cells had begun to change shape from the typical elon-
gated shape of HUVECs to smaller and rounder cells, and
viability counts decreased.
 
Uptake of oxidized LDL into macrophages
 
Monocytes were seeded onto 96-well plates at a density
of 2 
 

 
 10
 
6
 
 cells/ml. After 5 days, the cells appeared well
differentiated. Uptake of oxidized LDL into the macro-
phages was followed using a competitive assay, in which
Fig. 8. Electron paramagnetic resonance (EPR) spectrum of HU-
VECs incubated with 5,5-dimethyl-1-pyrroline N-oxide. Top: Experi-
mental spectrum. Bottom: Simulation showing correspondence of
the four-line features ascribed to the hydroxyl radical, using AN 
14.87 Gauss (G), AH  14.87 G. AU, arbitrary units.
Fig. 9. Intensity of the free radical signal observed in EPR spectra
as a function of incubation time. Diamond, no cells; square, with
cells;  (dashed line), no cells plus DTNB; triangle (dashed line),
with cells plus DTNB. Results were generated from three separate
experiments carried out on cells isolated from a single umbilical
cord. Experiments carried out on cells from another two umbilical
cords showed identical results. Error bars denote standard devia-
tion. The increase in EPR intensity with time is significant in all
cases (P  0.05), except in the absence of cells with DTNB. EPR in-
tensity (arbitrary units) is significantly higher in the presence of
cells. Asterisks show significantly lower EPR intensity than in the ab-
sence of DTNB (P  0.05).
TABLE 1. Oxidation of LDL in the presence of HUVECs and the
effect of a thiol-blocking reagent
Concentration of TBARS 
Sample 0 h 24 h 48 h
M
No cells 0.00 	 0.19 0.57 	 0.30 0.91 	 0.36
With cells 0.00 	 0.19 1.44 	 0.26a 3.17 	 0.32b
No cells 
 DTNB 0.00 	 0.19 0.43 	 0.19 0.48 	 0.47
With cells 
 DTNB 0.00 	 0.19 0.09 	 0.13a 0.09 	 0.75
HUVEC, human umbilical vein endothelial cell; TBARS, thiobar-
bituric acid reactive substances. Results (mean 	 SD) were corrected
by subtraction of the mean TBARS value measured at 0 h. Each result
was obtained from experiments carried out in triplicate on three differ-
ent HUVEC cultures (two for no cells 
 DTNB), each of which also
used a different LDL preparation.
a Significantly different on addition of DTNB (P  0.005).
b Significantly different from 24 h (P  0.005).
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partially oxidized experimental LDL competed with a fluo-
rescently labeled fully oxidized LDL for uptake into mac-
rophages. The results (Fig. 10) demonstrate a time-depen-
dent increase in uptake of experimentally oxidized LDL
and suggest that macrophage uptake of LDL occurs as
soon as oxidation of LDL starts. LDL oxidized by incuba-
tion with HUVECs for 72 h inhibited uptake of the fluo-
rescent oxidized LDL standard by macrophages over 16 h
by 59%.
DISCUSSION
Hcy export by HUVECs
We have shown that there is a continuous export of Hcy
from HUVECs, which is approximately linear over at least
72 h in culture, and that the export is stimulated by the
addition of methionine to the medium but reduced by the
addition of folinic acid. Although there have been earlier
reports of Hcy export from a variety of cells, this result is
significant because the cells used here are primary culture
human endothelial cells and because the effect of intra-
cellular folate is clearly evident. Thus, the results reported
here are likely to be of relevance to human cardiovascular
disease. Furthermore, earlier reports showed a marked re-
duction in Hcy export when cell density was high, raising
doubts about whether a confluent endothelial culture
would export much Hcy (19, 23). It is important to dem-
onstrate export from confluent endothelial cells, because
this is the most appropriate model for the in vivo vascular
endothelium. We have demonstrated that in the presence
of methionine a confluent layer produces 1.6 mol/l
Hcy/day, which is evidently sufficient to cause significant
LDL oxidation in vitro. In vivo, an increase in plasma tHcy
of 5 mol/l was found to have an odds ratio for coronary
artery disease or cerebrovascular disease of 1.8 (6), im-
plying that the Hcy export seen here is likely to be physio-
logically relevant. The effects of DTNB on LDL oxidation
confirm the role of thiols in this process. The effects of fo-
linic acid on Hcy export from HUVECs support previous
results (24). An inhibitory effect was demonstrated at a
concentration as low as 10 nM, although it became statisti-
cally significant only at 100 nM. Mean plasma folate con-
centrations in healthy cohorts are reported to lie in the
range of 10–25 nM (36, 37), although concentrations can
increase severalfold after supplementation (37–39). We
therefore conclude that an increase in plasma folate con-
centration can have a significant impact on the rate of ex-
port of Hcy from endothelial cells. We presume that this
effect is mediated by changes in intracellular folate, al-
though we have shown that intracellular folate is only
moderately responsive to extracellular folate. A 10-fold in-
crease in extracellular folate elicited a 2-fold increase in
intracellular folate. This is indicative of a tight control
over receptor-mediated transport of folate into cells, regu-
lated by cellular requirements for folate (40).
Flux through the methylation pathway is evidently an
important determinant of Hcy export. We confirm that
additional methionine in the medium elicits a more rapid
rate of export of Hcy from cells, as shown in other cell
types (19, 41), and also show that this is associated with a
clear increase in intracellular methionine. Additional me-
TABLE 2. Oxidation of LDL in the presence of HUVECs and the
effect of glutamate
Concentration of TBARS 
Sample 0 h 24 h
M
No cells 0.00 	 0.12 0.56 	 0.21
With cells 0.00 	 0.12 2.12 	 0.70a
With cells 
 glutamate 0.00 	 0.12 1.41 	 0.82a
Results were corrected as in Table 1. Each was obtained from three
or four measurements carried out on three different HUVEC cultures,
each of which also used a different LDL preparation.
a Significantly different on addition of glutamate (P  0.005).
Fig. 10. Competition of partially oxidized experimental LDL, oxidized by HUVECs for different lengths of
time (eLDL), with fluorescently labeled fully oxidized LDL (fLDL), for uptake into macrophages. Results are
shown as mean fluorescence values 	 SD from three measurements each on three different HUVEC and
macrophage preparations. As a positive control, fluorescent LDL was added in the absence of cells to give a
maximum signal; as negative controls, experimental oxidized LDL and PBS were added to give a baseline sig-
nal. Asterisks show fluorescence significantly lower than 0 h at P  0.05 (*) and P  0.005 (**). 
 at ASTO
N UNIVERSITY, on February 12, 2019
w
w
w
.jlr.org
D
ow
nloaded from
 
Nakano et al. Homocysteine exported from endothelial cells 491
thionine also stimulates a depletion of intracellular folate,
which we suggest may occur through inhibition of N5,10-
methylenetetrahydrofolate reductase (32), by a predicted
increase in SAM as methionine increases inside the cells.
The factors that regulate Hcy export are not understood,
but we suggest that intracellular SAM may play a role. A
similar suggestion has also been made by others (19).
Hcy exported from endothelial cells oxidizes LDL via the 
hydroxyl radical
The results reported for the oxidation of LDL in the
presence of DTNB are strong evidence that thiols ex-
ported from HUVECs are responsible for much of the
LDL oxidation seen in our experimental system. The ef-
fect of glutamate on LDL oxidation indicates that cysteine
also contributes to LDL oxidation. This requires further
investigation, but it is consistent with thiol exchange reac-
tions in plasma being important (42). We have shown that
the HUVECs produce a nearly linear increase in the
amount of free radical generated in the solution, this free
radical being most likely hydroxyl, because the EPR pa-
rameters of the predominant radical obtained are charac-
teristic of the hydroxyl radical. We have shown in previous
studies that the simultaneous presence of superoxide and
hydroxyl radicals in a composite spectrum with carbon-
centered radicals is resolvable (43). Therefore, any sig-
nificant presence of the superoxide radical anion in the
copper-Hcy reaction would have been observed by EPR spec-
trometry; thus, we are confident that the major radical
present is hydroxyl. Many authors have suggested that thi-
ols in the presence of copper or iron ions can produce
free radicals (44). Although some authors (10, 45, 46)
have suggested that the major oxidant species in copper-
mediated LDL oxidation is superoxide, others (47, 48)
have concluded that the hydroxyl radical may be impor-
tant. The participation of Hcy in the induction of radical
formation also suggests the thiol-derived RS• radical. Our
results confirm the generation of hydroxyl radicals. The
effect of the thiol blocker DTNB on hydroxyl radical gen-
eration in the cellular system is strongly supportive of thi-
ols being the major source of these radicals.
The hydroxyl radical is likely to be generated by the fol-
lowing reactions, in which the copper-catalyzed autoxi-
dation of Hcy in solution is associated with the production
of HO•:
(Eq. 1)
(Eq. 2)
(Eq. 3)
(Eq. 4)
(Eq. 5)
The reactive Cu
 species is rapidly oxidized to form the
superoxide radical anion, which is immediately proto-
nated in a medium of high H
 concentration to form hy-
drogen peroxide. In the presence of reactive Cu
, the
Cu2
 RSH+ Cu
 RS• H
+ +→
RS• RS•+ RSSR→
Cu
 O2+ Cu
2
 O2
•
+→
O2
• 2H
+ H2O2→
H2O2 Cu


+ Cu2
 OH HO•+ +→
Fenton reaction (formula 5) is facilitated to generate hy-
droxyl radicals. Our observation of the presence of hy-
droxyl radicals, and the absence of superoxide radicals, in-
dicates that superoxide is rapidly transformed to hydroxyl
via hydrogen peroxide. Thus, there is strong circumstan-
tial evidence that the Hcy generated by HUVECs primarily
produces hydroxyl radicals and thereby leads to LDL oxi-
dation. This is supported by the observed production of
HO• in a cell-free Hcy autoxidation system (our unpub-
lished observations).
As in our previous studies (15), the concentration of
copper used in our assays was 30 M and approximates
the in vivo concentration of plasma total copper. Most
plasma copper in vivo is bound by albumin and cerulo-
plasmin, and although tightly bound this copper appears
to be redox active (49). In our study, we used a physiologi-
cal concentration of albumin, thereby binding copper to
give approximately the same concentration of free copper
as found in plasma.
We have previously demonstrated (15) that Hcy at phys-
iological concentrations can induce the oxidation of LDL
through a copper-dependent pathway. Hcy is rapidly oxi-
dized to homocystine both in vitro and in vivo (11, 24),
such that only 1% of the total homocyst(e)ine present
in vivo is Hcy (50). The results presented here suggest
that it is the continuous export of Hcy from endothelial
cells that gives rise to sustained amounts of Hcy in plasma,
and thereby to oxidation of LDL in vivo, via free radical
mechanisms.
LDL uptake by macrophages
We have also shown that LDL oxidized by our experi-
mental system is taken up by macrophages. This is not un-
expected, because many others have shown that oxidized
LDL is taken up by macrophages and incorporated to
form foam cells (51, 52). The significance of this result is
that we have shown in a single system that all of the steps
suggested to be responsible for Hcy-dependent athero-
sclerosis do indeed occur in quantities sufficient to lead to
the formation of atherosclerotic plaques: Hcy is exported
from endothelial cells, it is oxidized in the presence of
copper ions to form free radicals, LDL is oxidized by the
free radicals, and the oxidized LDL is taken up by macro-
phages. These results lend powerful support to this sug-
gested mechanism for Hcy involvement in atherosclerosis
(10).
The authors acknowledge support from Biotechnology and Bi-
ological Sciences Research Council Grant 50/C16643 for this
work.
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